leisure time -WSS

leisure time

author：knowledge 2025-10-06 08:27:37 - browse：9495

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

Fresh off of the news that its drug Wegovy may not just help people lose weight, but could also lower cardiac risks, Novo Nordisk doubled down on its obesity drug pipeline Thursday, acquiring a small Canadian biotech with a new approach to weight loss.

Novo will spend up to $1 billion to buy Inversago Pharma, which is developing an oral obesity drug that targets the cannabinoid receptor CB1. It’s the second big obesity acquisition this year, following Eli Lilly’s move to purchase startup Versanis Bio.

Drugs like Wegovy are in a class called GLP-1 drugs, which mimic the effects of the glucagon-like peptide 1 hormone that help people feel full by targeting the hormone’s receptors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Are infertility treatments 'essential' during the Covid

explore

WSS

Extensive review finds private equity owners jack up cost of care

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

The SUPPORT Act is critical to fighting the opioid crisis

When a patient nears the end, a feared therapy can comfort

Three issues to watch in global health in 2024

explore

leisure time

focus

Drug repurposing or repositioning? The language matters

Generative AI mines health records to identify patients’ social needs

Hollywood unions extend contract negotiations for actors

How I ended up pumping milk in a bathroom stall at JPM 2024

Dobbs anniversary: the lost opportunity of abortion as health care

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Medicare details structure of new drug price negotiation program

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Moonlake's readout produced a cash windfall. Risks remain

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

Wikipedia

Risky weight loss products often used by teens globally, per study

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Heart disease and mental health: A look at cardiac psychology

A new ‘biological computer' targets cancer while sparing healthy cells

US jobless claims fall again as labor market continues to flash strength

Doulas covered by Medicaid under New York's new plan

hotspot

hotspot

explore

knowledge